SEARLE partners with Beximco for supply of Covid-19 drug Remdesivir 

This partnership will provide an immediate supply of the finished product at an affordable price and will help healthcare providers of Pakistan to treat their hospitalised Covid-19 patients without any delay.

The Searle Company Limited has successfully entered into an exclusive licensing and marketing agreement with Beximco Pharmaceuticals, Bangladesh for marketing of Covid-19 drug Remdesivir, informed the company in a statement to the Pakistan Stock Exchange on Friday.

This partnership will provide an immediate supply of the finished product at an affordable price and will help healthcare providers of Pakistan to treat their hospitalised Covid-19 patients without any delay, the statement added.  “Initially, the company is planning to import Remdesivir in finished form (ready to use) to meet the country’s urgent requirements. The company is also planning to donate a sizeable quantity to the government of Pakistan which is actively fighting against this pandemic”, the statement maintained.

Beximco is the first company in the world which developed and introduced generic of Remdesivir for the treatment of Covid-19. Remdesivir is a direct acting antiviral drug that inhibits viral RNA synthesis. Remdesivir is administered intravenously and is authorised for the treatment of hospitalised patients with severe COVID-19 disease. 

Remdesivir has been granted emergency use authorisation (EUA) by the US Food and Ddrug Administration (FDA) and authorities in Japan to treat hospitalised patients with severe Covid-19.

Article continues after this advertisement

 

- Advertisement -

9 COMMENTS

  1. Why donating? are you giving away profit of investors who have trusted you with 250 million dollars of market capitalization.

    • I am an investor, with a sizeable chunk in searl. But this is an excellent gesture, sorry to say I’m disappointed in you Kiddo!!

      • We can donate as much as we want but such kind of corporate donation should only be given from board of director renumerations. Not from cash flow the comapny

  2. We can donate as much as we want but such kind of corporate donation should only be given from board of director renumerations. Not from cash flow the comapny

  3. Kindly inform me about the actual date of Remdesivir ..or any other problem by the government.

  4. Can u tell me the actual amount of this Remdesivir or round about.2nd is how will our country buy it ? In dollars or pak Rupees.

  5. why searle company is not doing anything for investor as we have bought searl @ 680(average cost 500) but the current rate is 270approx when we will be reached at breakeven point as i am totally stucked. Company is also not giving bonus shares and other measures for their investor.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Must Read

China exports soar to highest level in decades after Covid-19 hit

BEIJING: China's export growth jumped to the highest in over two decades, official data showed Sunday, with imports also surging in a sharp bounce...